Skip to main content
. 2008 May 14;14(18):2818–2824. doi: 10.3748/wjg.14.2818

Table 4.

Comparison of groups by categories n (%)

Categories Group 1 Group 2 Group 3 χ2/P
Necrosis
No change 5 (35.7) 12 (85.7) 7 (50) χ2 = 17.20
Slight 7 (50) 0 (0) 1 (7.1) P < 0.050
Moderate 2 (14.3) 2 (14.3) 6 (42.9)
Regenerative activity
Slight 6 (42.9) 13 (92.9) 6 (42.9) χ2 = 10.22
Moderate 5 (35.7) 1 (7.1) 6 (42.9) P < 0.050
Severe 3 (21.4) 0 (0) 2 (14.2)
Ductular proliferation
Slight 0 (0) 6 (42.9) 1 (7.1) χ2 = 12.43
Moderate 5 (35.7) 5 (35.7) 4 (28.6) P < 0.050
Severe 9 (64.3) 3 (21.4) 9 (64.3)
Fibroblastic activity
Slight 1 (7.1) 9 (64.3) 1 (7.1) χ2 = 31.06
Moderate 9 (64.3) 4 (28.6) 11 (78.6) P < 0.001
Severe 4 (28.6) 1 (7.1) 2 (14.3)
Kupffer cell abnormalities
Absence 6 (42.9) 12 (85.7) 7 (50) χ2 = 6.13
Presence 8 (57.1) 2 (14.3) 7 (50) P < 0.050
Sinusoidal congestion
Absence 13 (92.9) 9 (64.3) 14 (100) χ2 = 8.17
Presence 1 (7.1) 5 (35.7) 0 (0) P < 0.050
Portal central venous phlebitis
Absence 3 (21.4) 6 (42.9) 0 (0) χ2 = 7.64
Presence 11 (78.6) 8 (57.1) 14 (100) P < 0.050
IFN-γ (pg/mL) 349.46 ± 125.15 764.61 ± 191.95 450.21 ± 98.25 P < 0.001
IL-6 (pg/mL) 839.84 ± 245.05 466.5 ± 106.86 710.02 ± 167.75 P < 0.001